policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Webinar explains federal guidance on manufacturing of animal cells and tissues
The Food and Drug Administration posted a prerecorded webinar this fall explaining draft guidance documents on good manufacturing practices and donor…
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
A bucking-bull veterinarian in the making
When Dr. Gary D. Warner asked his daughter Kelly why she wanted to be a large animal veterinarian over anything anything else, he wasn’t necessarily…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
Veterinarians among those charged in widespread horse doping scheme
Federal prosecutors have arrested several veterinarians, trainers, and other horse racing professionals on charges relating to systematic, covert…